Yazar "Kallend, David" için listeleme
-
Long-term Efficacy of Lerodalcibep in 1,468 Patients at Very High and High Risk for CVD in the 72 week Open-Label Extension Trial
Kereiakes, Dean; Fourie, Nyda; Scott, Russell; Asprusten, Emil; Yalim, Zafer; Vest, Jeff; Kallend, David (Lippincott Williams & Wilkins, 2024)[Abstract Not Available]
